The Business Development & Acquisitions function drives the advancement of AbbVie’s R&D pipeline and commercial business by assessing and executing key strategic transactions. Example transaction types include in-licensing, out-licensing, co-development / co-promotion, collaboration, and option deals, as well as divestiture / carve-outs and mergers & acquisitions. The Oncology Director of Business Development & Acquisitions, supports those efforts through development of analytical assessments to determine opportunity viability, communication of findings to senior management and participation in terms and contract negotiations for the Oncology Therapeutic Area.
Responsibilities:
- Supports the achievement of overall business development objectives, strategies and tactics for growth of AbbVie’s pharmaceutical business.
- Partners with Search & Evaluation and Global Commercial Development team members as well as key Therapeutic Area subject matter experts to efficiently identify and advance opportunities.
- Works constructively with key stakeholders and cross-functional teams to conduct timely initial technical assessments and full due diligence of prioritized opportunities, with specific responsibility for business and financial diligence.
- Presents business components of key opportunities to therapeutic area and enterprise governance bodies concisely, demonstrating strong executive presence and mastery of both strategic rationale and detailed findings for individual opportunity, to enable effective decision-making.
- Leads deal negotiations, including collaboration with Transactions Legal, to secure both internal and partner alignment on all key terms from initial discussions of economics through contract execution.
- Represents BD&A, as needed, during key internal planning processes (e.g., Business Development Strategy, Long Range Plan) and ad hoc strategic projects as requested by Executive Leadership Team
- Participates in external partnering meetings and conferences to build individual network and advance AbbVie’s position as a biopharma “partner of choice.”
- Monitors global and domestic industry and transaction trends and activities.